JP2002308835A - テルビナフィンの製造方法 - Google Patents
テルビナフィンの製造方法Info
- Publication number
- JP2002308835A JP2002308835A JP2002056007A JP2002056007A JP2002308835A JP 2002308835 A JP2002308835 A JP 2002308835A JP 2002056007 A JP2002056007 A JP 2002056007A JP 2002056007 A JP2002056007 A JP 2002056007A JP 2002308835 A JP2002308835 A JP 2002308835A
- Authority
- JP
- Japan
- Prior art keywords
- terbinafine
- mmol
- copper
- palladium
- base
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- DOMXUEMWDBAQBQ-WEVVVXLNSA-N terbinafine Chemical compound C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 DOMXUEMWDBAQBQ-WEVVVXLNSA-N 0.000 title claims abstract description 26
- 229960002722 terbinafine Drugs 0.000 title claims abstract description 23
- 238000004519 manufacturing process Methods 0.000 title claims abstract 4
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims abstract description 18
- 238000006243 chemical reaction Methods 0.000 claims abstract description 9
- 229910052763 palladium Inorganic materials 0.000 claims abstract description 9
- VMQMZMRVKUZKQL-UHFFFAOYSA-N Cu+ Chemical class [Cu+] VMQMZMRVKUZKQL-UHFFFAOYSA-N 0.000 claims abstract description 7
- 150000001875 compounds Chemical class 0.000 claims abstract description 4
- 238000000034 method Methods 0.000 claims description 15
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims description 10
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 9
- HQABUPZFAYXKJW-UHFFFAOYSA-N butan-1-amine Chemical compound CCCCN HQABUPZFAYXKJW-UHFFFAOYSA-N 0.000 claims description 8
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 claims description 6
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 claims description 4
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 claims description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 4
- BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical compound CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 claims description 2
- 150000001412 amines Chemical class 0.000 claims description 2
- 229940043279 diisopropylamine Drugs 0.000 claims description 2
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical group I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 claims description 2
- IOQPZZOEVPZRBK-UHFFFAOYSA-N octan-1-amine Chemical compound CCCCCCCCN IOQPZZOEVPZRBK-UHFFFAOYSA-N 0.000 claims description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 2
- CGHIBGNXEGJPQZ-UHFFFAOYSA-N 1-hexyne Chemical group CCCCC#C CGHIBGNXEGJPQZ-UHFFFAOYSA-N 0.000 claims 1
- 125000005843 halogen group Chemical group 0.000 claims 1
- PPWNCLVNXGCGAF-UHFFFAOYSA-N 3,3-dimethylbut-1-yne Chemical group CC(C)(C)C#C PPWNCLVNXGCGAF-UHFFFAOYSA-N 0.000 abstract description 5
- 238000000746 purification Methods 0.000 abstract description 2
- 239000012467 final product Substances 0.000 abstract 1
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 30
- 238000002360 preparation method Methods 0.000 description 8
- 238000001816 cooling Methods 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 229920002554 vinyl polymer Polymers 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 5
- 229910021595 Copper(I) iodide Inorganic materials 0.000 description 5
- LSXDOTMGLUJQCM-UHFFFAOYSA-M copper(i) iodide Chemical compound I[Cu] LSXDOTMGLUJQCM-UHFFFAOYSA-M 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- MQRIUFVBEVFILS-UHFFFAOYSA-N n-methyl-1-naphthalen-1-ylmethanamine Chemical compound C1=CC=C2C(CNC)=CC=CC2=C1 MQRIUFVBEVFILS-UHFFFAOYSA-N 0.000 description 4
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 230000003197 catalytic effect Effects 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 229960000699 terbinafine hydrochloride Drugs 0.000 description 3
- NMPVEAUIHMEAQP-UHFFFAOYSA-N 2-Bromoacetaldehyde Chemical compound BrCC=O NMPVEAUIHMEAQP-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000011343 solid material Substances 0.000 description 2
- 230000000707 stereoselective effect Effects 0.000 description 2
- ZAIDIVBQUMFXEC-UHFFFAOYSA-N 1,1-dichloroprop-1-ene Chemical compound CC=C(Cl)Cl ZAIDIVBQUMFXEC-UHFFFAOYSA-N 0.000 description 1
- ZDHCSCQGRLSOQG-UHFFFAOYSA-N 2-chloroethenamine Chemical compound NC=CCl ZDHCSCQGRLSOQG-UHFFFAOYSA-N 0.000 description 1
- 101100408296 Autographa californica nuclear polyhedrosis virus AC24 gene Proteins 0.000 description 1
- 102100022005 B-lymphocyte antigen CD20 Human genes 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 229910021589 Copper(I) bromide Inorganic materials 0.000 description 1
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 1
- 101000897405 Homo sapiens B-lymphocyte antigen CD20 Proteins 0.000 description 1
- 241001068914 Melicope knudsenii Species 0.000 description 1
- 102000003729 Neprilysin Human genes 0.000 description 1
- 108090000028 Neprilysin Proteins 0.000 description 1
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
- IHJICFFGQVAWEV-UHFFFAOYSA-N [Li].CC(C)(C)C#C Chemical group [Li].CC(C)(C)C#C IHJICFFGQVAWEV-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical class [H]C([H])([H])C(*)=O 0.000 description 1
- 150000001345 alkine derivatives Chemical group 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- 238000005576 amination reaction Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 150000001879 copper Chemical class 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- NKNDPYCGAZPOFS-UHFFFAOYSA-M copper(i) bromide Chemical compound Br[Cu] NKNDPYCGAZPOFS-UHFFFAOYSA-M 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 125000003700 epoxy group Chemical group 0.000 description 1
- DIRFUJHNVNOBMY-UHFFFAOYSA-N fenobucarb Chemical compound CCC(C)C1=CC=CC=C1OC(=O)NC DIRFUJHNVNOBMY-UHFFFAOYSA-N 0.000 description 1
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 1
- 150000004820 halides Chemical group 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- NVSYANRBXPURRQ-UHFFFAOYSA-N naphthalen-1-ylmethanamine Chemical compound C1=CC=C2C(CN)=CC=CC2=C1 NVSYANRBXPURRQ-UHFFFAOYSA-N 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 125000002524 organometallic group Chemical group 0.000 description 1
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- AMLFJZRZIOZGPW-UHFFFAOYSA-N prop-1-en-1-amine Chemical class CC=CN AMLFJZRZIOZGPW-UHFFFAOYSA-N 0.000 description 1
- 238000006268 reductive amination reaction Methods 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 229910000080 stannane Inorganic materials 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- -1 vinyl halide Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
- C07C209/68—Preparation of compounds containing amino groups bound to a carbon skeleton from amines, by reactions not involving amino groups, e.g. reduction of unsaturated amines, aromatisation, or substitution of the carbon skeleton
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2001A000430 | 2001-03-02 | ||
| IT2001MI000430A ITMI20010430A1 (it) | 2001-03-02 | 2001-03-02 | Metodo per la sintesi di terbinafina |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002308835A true JP2002308835A (ja) | 2002-10-23 |
| JP2002308835A5 JP2002308835A5 (enExample) | 2005-08-25 |
Family
ID=11447087
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002056007A Pending JP2002308835A (ja) | 2001-03-02 | 2002-03-01 | テルビナフィンの製造方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US6515181B2 (enExample) |
| EP (1) | EP1236709B1 (enExample) |
| JP (1) | JP2002308835A (enExample) |
| AT (1) | ATE380171T1 (enExample) |
| CA (1) | CA2373813A1 (enExample) |
| DE (1) | DE60223862T2 (enExample) |
| IT (1) | ITMI20010430A1 (enExample) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006508156A (ja) * | 2002-11-29 | 2006-03-09 | ディファルマ・ソシエタ・ペル・アチオニ | 触媒として白金を用いたテルビナフィンの製造方法 |
| JP2007504110A (ja) * | 2003-08-29 | 2007-03-01 | ノバルティス アクチエンゲゼルシャフト | テルビナフィンの精製法 |
| JP2008501784A (ja) * | 2004-06-09 | 2008-01-24 | エッフェ．イー．エッセ． ファブリカ イタリアーナ シンテーティチ エッセ．ペー．アー． | テルビナフィンおよびその誘導体を合成するための方法 |
| JP2008531513A (ja) * | 2005-02-25 | 2008-08-14 | ノバルティス アクチエンゲゼルシャフト | 精製方法 |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7244703B2 (en) * | 2001-06-22 | 2007-07-17 | Bentley Pharmaceuticals, Inc. | Pharmaceutical compositions and methods for peptide treatment |
| US20050197512A1 (en) * | 2003-08-29 | 2005-09-08 | Ulrich Beutler | Purification process |
| ES2348303T3 (es) | 2003-12-08 | 2010-12-02 | Cpex Pharmaceuticals, Inc. | Composiciones farmacauticas y procedimientos de tratamiento con insulina. |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4755538A (en) * | 1987-04-14 | 1988-07-05 | The B. F. Goodrich Company | Skinless porous particle PVC resin and process for producing same |
| NZ280065A (en) * | 1995-09-20 | 1998-04-27 | Apotex Inc | Preparation of n-alkyl-n-(1-naphthylmethyl)alk-2-en-4-ynylamine derivatives |
-
2001
- 2001-03-02 IT IT2001MI000430A patent/ITMI20010430A1/it unknown
-
2002
- 2002-02-22 EP EP02003969A patent/EP1236709B1/en not_active Expired - Lifetime
- 2002-02-22 DE DE60223862T patent/DE60223862T2/de not_active Expired - Fee Related
- 2002-02-22 AT AT02003969T patent/ATE380171T1/de not_active IP Right Cessation
- 2002-02-28 US US10/085,699 patent/US6515181B2/en not_active Expired - Fee Related
- 2002-02-28 CA CA002373813A patent/CA2373813A1/en not_active Abandoned
- 2002-03-01 JP JP2002056007A patent/JP2002308835A/ja active Pending
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006508156A (ja) * | 2002-11-29 | 2006-03-09 | ディファルマ・ソシエタ・ペル・アチオニ | 触媒として白金を用いたテルビナフィンの製造方法 |
| JP2007504110A (ja) * | 2003-08-29 | 2007-03-01 | ノバルティス アクチエンゲゼルシャフト | テルビナフィンの精製法 |
| KR101233024B1 (ko) * | 2003-08-29 | 2013-02-13 | 노파르티스 아게 | 테르비나핀의 정제 방법 |
| JP2008501784A (ja) * | 2004-06-09 | 2008-01-24 | エッフェ．イー．エッセ． ファブリカ イタリアーナ シンテーティチ エッセ．ペー．アー． | テルビナフィンおよびその誘導体を合成するための方法 |
| JP2008531513A (ja) * | 2005-02-25 | 2008-08-14 | ノバルティス アクチエンゲゼルシャフト | 精製方法 |
| JP2012176960A (ja) * | 2005-02-25 | 2012-09-13 | Novartis Ag | 精製方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| EP1236709A2 (en) | 2002-09-04 |
| US6515181B2 (en) | 2003-02-04 |
| US20020123651A1 (en) | 2002-09-05 |
| ITMI20010430A1 (it) | 2002-09-02 |
| CA2373813A1 (en) | 2002-09-02 |
| EP1236709A3 (en) | 2003-11-26 |
| DE60223862D1 (de) | 2008-01-17 |
| ATE380171T1 (de) | 2007-12-15 |
| DE60223862T2 (de) | 2008-03-20 |
| EP1236709B1 (en) | 2007-12-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5604424B2 (ja) | アポトーシス促進剤ａｂｔ−２６３の調製のための方法 | |
| JP5996428B2 (ja) | １−（２−ハロビフェニル−４−イル）−シクロプロパンカルボン酸の誘導体の調製方法 | |
| US20040106818A1 (en) | Process for the preparation of cyclohexanol derivatives | |
| JP2011530544A (ja) | シクロアルキル置換ピペラジン化合物の調製方法 | |
| JP2002308835A (ja) | テルビナフィンの製造方法 | |
| EP2278970B1 (en) | Process for the preparation of donepezil hydrochloride | |
| CN1993369B (zh) | 特比萘芬及其衍生物的合成方法 | |
| JP7669272B2 (ja) | モルヒナン誘導体の製造方法 | |
| Vasilevsky et al. | Ethyl vinyl ether--an agent for protection of the pyrazole NH-fragment. A convenient method for the preparation of N-unsubstituted 4-Alkynylpyrazoles | |
| JP6324567B2 (ja) | モリンドン及びその塩の製造方法 | |
| US6881845B2 (en) | Process for preparing (±)trans-4-p-fluorophenyl-3-hydroxymethyl-1-methylpiperidine | |
| KR100459275B1 (ko) | 터비나핀 또는 그의 염산염의 제조방법 | |
| CN112707899B (zh) | 一种奎宁醇的制备方法 | |
| JP2007515459A (ja) | トルテロジンを得るための方法 | |
| JP5452165B2 (ja) | キヌクリジン類の製造法 | |
| TWI310763B (en) | Processes and intermediates for the preparations of prostaglandins | |
| JP6911015B2 (ja) | インダンアミン誘導体の製法及び新規の合成中間体 | |
| JP4018816B2 (ja) | シクロヘプテノン誘導体及びその製造方法並びにそれを利用してシクロヘプトイミダゾール誘導体を製造する方法 | |
| JP3010756B2 (ja) | 光学活性アルコールの製造方法 | |
| JP4286694B2 (ja) | 新規なグリニャール試薬及びそれを用いた脂肪族アルキニルグリニャール化合物の製造方法 | |
| JP2023503647A (ja) | １－（４－ベンジルオキシ－ベンジル）－３－メチル－チオ尿素の新規結晶形の製造方法 | |
| Elguero | Sergei F. Vasilevsky", SvetlanaV. Klyatskaya", Eugene V. Tretyakov", and | |
| CN1910180A (zh) | 制备2－(乙氧基甲基)－托烷衍生物的方法 | |
| WO2001002371A1 (en) | Optically active piperazine compounds, intermediates for the preparation of the same and processes for the preparation of both | |
| JP2005047836A (ja) | １−アルキル−３−ピペリジンエステル類の製造方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050222 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20050222 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20080122 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20080624 |